Imexpharm

Imexpharm Change in Working Capital

The Change in Working Capital of Imexpharm (IMP.VN) as of Oct 27, 2026 is -232.16 B VND. In the previous year, Change in Working Capital was -72.92 B VND — a change of 218.38% (lower).

Change in Working Capital

-232.16 BVND

YoY

218.38%

Last updated:

Change in Working Capital of Imexpharm is 2025 -232.16 B VND. Change in Working Capital of Imexpharm was 2024 -72.92 B VND. It decreases by 218.38% lower compared to the previous year.

The Imexpharm Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2018
-77.29 B VND
Jan 1, 2019
-97.25 B VND
Jan 1, 2020
-178.14 B VND
Jan 1, 2021
49.58 B VND
Jan 1, 2022
120.66 B VND
Jan 1, 2023
-378.88 B VND
Jan 1, 2024
-72.92 B VND
Jan 1, 2025
-232.16 B VND
The Imexpharm Change in Working Capital history
YEARChange in Working CapitalYoY
-232.16 BVND+218.38%
-72.92 BVND-80.75%
-378.88 BVND-414.00%
120.66 BVND+143.36%
49.58 BVND-127.83%
-178.14 BVND+83.18%
-97.25 BVND+25.82%
-77.29 BVND+0.00%
-77.29 BVND-11.21%
-87.06 BVND-16.75%
-104.58 BVND-10.64%
-117.02 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Change in Working Capital of Imexpharm is -232.16 B VND in 2025.

Change in Working Capital of Imexpharm changed from -72.92 B VND to -232.16 B VND, representing a 218.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Imexpharm

All Key Metrics — Imexpharm